Testing a drug for enlarged prostate symptoms
Treatments studied
Part of Kidney & urinary clinical trials.
This trial tests whether a drug called adalimumab (a TNF blocker) can improve symptoms of an enlarged prostate. It is for men aged 45-80 with a large prostate and bothersome urinary symptoms who have not used this type of medication before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 45 and 80 years old
- A doctor has diagnosed you with an enlarged prostate (BPH)
- Your prostate is at least 60 mL in size (checked by ultrasound or MRI)
- You have moderate to severe urinary symptoms (score of 8 or higher on a standard questionnaire)
- You have not taken a TNF blocker drug (like adalimumab, etanercept, or infliximab) before
- You do not have any of the following: active infection, tuberculosis, hepatitis B, cancer, or an autoimmune disease (like rheumatoid arthritis or Crohn's)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new minimally invasive treatment device called the ALPFA GRAIL System to see if it safely and effectively reduces urinary symptoms caused by an enlarged prostate. The procedure aims to improve urinary flow and reduce bothersome symptoms like frequent urination.
This study tests a better way to manage benign prostatic hyperplasia (BPH) by using your answers to regular health questionnaires. It may help your care team make more informed decisions about your symptoms and treatment over time.
This trial studies whether taking anti-inflammatory medicine (ibuprofen or similar “NSAID” drugs) can improve what doctors learn in people whose PSA blood test is higher than expected and who need more prostate testing. It may help reduce unnecessary procedures or improve next-step decisions, but only if you meet safety and eligibility rules.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
This trial tests a new, once-daily tablet (H077) compared to the standard medicine silodosin for treating symptoms of an enlarged prostate. It aims to see if the new medicine works as well and is safe.
This trial tests a new medicine (DNN.65.21.005) to see if it helps men with an enlarged prostate who have trouble urinating. It may be an option if you are 50 or older and have symptoms like needing to go often or having a weak stream.
Hear when a new Benign Prostatic Hyperplasia (BPH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.